Iriban may be available in the countries listed below.
Ingredient matches for Iriban
Mebeverine hydrochloride (a derivative of Mebeverine) is reported as an ingredient of Iriban in the following countries:
- Bangladesh
International Drug Name Search
Iriban may be available in the countries listed below.
Mebeverine hydrochloride (a derivative of Mebeverine) is reported as an ingredient of Iriban in the following countries:
International Drug Name Search
Amprace may be available in the countries listed below.
Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Amprace in the following countries:
International Drug Name Search
Dolophine Solution may cause severe and sometimes fatal heart and breathing problems. These problems may occur some time after you take a dose. Tell your doctor right away if you develop any new or worsening symptoms such as slowed or shallow breathing or irregular heartbeat. Your doctor will perform heart and lung function tests to check for side effects while you take Dolophine Solution. Keep all doctor and laboratory appointments. Talk with your doctor and be sure you understand the risks and benefits of using Dolophine Solution.
Do not take more than the recommended dose or take Dolophine Solution more often than it is prescribed. This can lead to overdose and possible death.
Treating moderate to severe pain that is not relieved by other pain medicines. It is used in the temporary treatment of narcotic addiction as part of a treatment program in patients who are unable to take medicine by mouth. It may also be used for other conditions as determined by your doctor.
Dolophine Solution is a narcotic analgesic. It works by acting on opiate pain receptors in the brain and on smooth muscle to provide pain relief.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Dolophine Solution. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Dolophine Solution. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Dolophine Solution may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Dolophine Solution as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Dolophine Solution.
When used for long periods of time or at high dose, Dolophine Solution may not work as well and may require higher doses to obtain the same effect as when originally taken. This is known as TOLERANCE. Talk with your doctor if Dolophine Solution stops working well. Do not take more than prescribed.
Some people who use Dolophine Solution for a long time may develop a need to continue taking it. People who take high doses are also at risk. This is known as DEPENDENCE or addiction.
If you stop taking Dolophine Solution suddenly, you may have WITHDRAWAL symptoms. These may include convulsions, tremor, stomach and muscle cramps, vomiting, and sweating. Do not stop therapy suddenly or change the dosage without asking your doctor. Discuss overuse with your doctor or pharmacist.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Constipation; dizziness; drowsiness; dry mouth; headache; increased sweating; itching; lightheadedness; nausea; pain, redness, or swelling at the injection site; vomiting; weakness.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); confusion; decreased sexual desire or ability; excessive drowsiness; fainting; fast, slow, or irregular heartbeat; hallucinations; loss of appetite; menstrual changes; mental or mood changes (eg, agitation, disorientation, exaggerated sense of well-being); seizures; severe or persistent dizziness or lightheadedness; severe or persistent pain, redness, or swelling at the injection site; shortness of breath; slow or shallow breathing; swelling of the arms, feet, or legs; trouble sleeping; trouble urinating; unusual bruising or bleeding.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Dolophine side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include cold and clammy skin; coma; fainting; fast, slow, or irregular heartbeat; muscle weakness; pinpoint pupils; severe dizziness, drowsiness, or lightheadedness; slow, shallow, or difficult breathing.
Store Dolophine Solution at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Dolophine Solution out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Dolophine Solution. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Mitokebir may be available in the countries listed below.
Mitomycin is reported as an ingredient of Mitokebir in the following countries:
International Drug Name Search
Metformin-Zentiva may be available in the countries listed below.
Metformin is reported as an ingredient of Metformin-Zentiva in the following countries:
International Drug Name Search
Darolan Hoestprikkeldempend may be available in the countries listed below.
Dextromethorphan hydrobromide (a derivative of Dextromethorphan) is reported as an ingredient of Darolan Hoestprikkeldempend in the following countries:
International Drug Name Search
Ferromas may be available in the countries listed below.
Ferrous Sulfate is reported as an ingredient of Ferromas in the following countries:
International Drug Name Search
Meropenem Labatec may be available in the countries listed below.
Meropenem trihydrate (a derivative of Meropenem) is reported as an ingredient of Meropenem Labatec in the following countries:
International Drug Name Search
Novell-Eutropin may be available in the countries listed below.
Somatropine is reported as an ingredient of Novell-Eutropin in the following countries:
International Drug Name Search
Anelat may be available in the countries listed below.
Folic Acid is reported as an ingredient of Anelat in the following countries:
International Drug Name Search
Inate may be available in the countries listed below.
Zinc Sulfate is reported as an ingredient of Inate in the following countries:
International Drug Name Search